MLYS Mineralys Therapeutics, Inc. Common Stock

USD 13.78 -0.18 ( -1.29)%
Icon

Mineralys Therapeutics, Inc. Common Stock (MLYS) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 13.78

-0.18 (-1.29)%

N/A

0.41M

USD 30.00(+123.05%)

USD 22.00 (+59.65%)

Icon

MLYS

Mineralys Therapeutics, Inc. Common Stock (USD)
COMMON STOCK | NSD
USD 13.78
-0.18 ( -1.29)%

User / Independent Analyst Ratings

Please use the “Submit your target” button above to submit your own rating and target

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...